si02 stock price

What does Si02 stand for?

SI02 Quote - OSSIAM SHILLER BARCLAYS CAPE US SECTOR VALUE TR Fund - Bloomberg Markets Performance charts for OSSIAM SHILLER BARCLAYS CAPE US SECTOR VALUE TR (SI02 - Type ETF) including intraday, historical and comparison charts, technical analysis and trend lines.

Who is SiO2 medical products?

Sio2 Medical Products, Inc. was founded in 2011. The company's line of business includes the manufacturing of industrial rubber goods, rubberized fabrics, and miscellaneous rubber specialties.

What are the characteristics of SiO2 coating?

Essential characteristics of SiO2’s patented materials coating include thermal stability and integrity, chemical stability, a gas barrier, mechanical durability, no breakage, and precision molding.

What is SiO2 material science?

SiO2 Materials Science, a privately-owned U.S. advanced materials science corporation introducing breakthrough disruptive technology for packaging biological pharmaceuticals and vaccines, today announced a $143 million agreement with the federal government. The agreement with the Department of Defense’s Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) in partnership with the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS), accelerates the production scale-up of the company’s state-of-the-art, patented, primary packaging platform for storing novel coronavirus (SARS-CoV-2) vaccines and therapeutics.

Why is SiO2 important to Auburn?

SiO2 is critical to Auburn because the company’s advanced materials science platforms are critical to our nation’s fight against this pandemic and future health threats.”. Bobby Abrams, Chief Executive Officer of SiO2, stated, “The pandemic presents an enormous challenge for all people.

What is the mission of the ASPR?

The mission of ASPR is to save lives and protect Americans from 21st century health security threats. Within ASPR, BARDA invests in the innovation, advanced research and development, acquisition, and manufacturing of medical countermeasures – vaccines, drugs, therapeutics, diagnostic tools, and non-pharmaceutical products needed to combat health security threats. To learn more about the whole-of-America response to the coronavirus pandemic, visit www.coronavirus.gov, and for more information about BARDA’s COVID-19 portfolio, visit www.medicalcountermeasures.gov .

What is SiO2 used for?

SiO2’s patented materials science is a combination of a plastic container with a microscopic, thin, undetectable to the naked eye, pure glass coating for biological drugs and vaccines.

Where is SiO2 made?

SiO2 currently employs more than 200 engineers, scientists, and technicians, most of whom live in Lee County, Alabama and are Auburn University graduates, in a 165,000 square foot manufacturing plant in Auburn. The company expects to hire 200 more.

What are the characteristics of SiO2?

Essential characteristics of SiO2’s patented materials coating include thermal stability and integrity, chemical stability, a gas barrier, mechanical durability, no breakage, and precision molding .

Is SiO2 safe for use?

SiO2 vials also can withstand 1,500 pounds of direct force, which potentially saves millions of dollars from breaking on filling lines and minimizes loss in the supply chain; and the vials are shatterproof, making them safe for use by healthcare staff and patients.

What is Siox 2021?

NEW YORK and RESEARCH TRIANGLE PARK, N.C, May 19, 2021 (GLOBE NEWSWIRE) -- Sio Gene Therapies Inc. (NASDAQ: SIOX), a clinical-stage company focused on developing gene therapies to radically improve the lives of patients with neurodegenerative diseases, announced today that the company will present and participate in 1-on-1 investor meetings at the UBS Global Healthcare Virtual Conference taking place May 24-26, 2021. Details on the presentation can be found below. Date:Monday, May 24, 2021Time:10:00 AM ETParticipation Format:Company presentationPresenter:Pavan Cheruvu, MD, Chief Executive OfficerWebcast:Click here About Sio Gene Therapies Sio Gene Therapies combines cutting-edge science with bold imagination to develop genetic medicines that aim to radically improve the lives of patients. Our current pipeline of clinical-stage candidates includes the first potentially curative AAV-based gene therapies for GM1 gangliosidosis and Tay-Sachs/Sandhoff diseases, which are rare and uniformly fatal pediatric conditions caused by single gene deficiencies. We are also expanding the reach of gene therapy to highly prevalent conditions such as Parkinson’s disease, which affects millions of patients globally. Led by an experienced team of gene therapy development experts, and supported by collaborations with premier academic, industry and patient advocacy organizations, Sio is focused on accelerating its candidates through clinical trials to liberate patients with debilitating diseases through the transformational power of gene therapies. For more information, visit www.siogtx.com. Contacts: Media Josephine Belluardo, Ph.D.LifeSci Communications (646) [email protected] [email protected] Investors and Analysts Parag V. Meswani, PharmDSio Gene Therapies Inc.Chief Commercial [email protected]

What is GM1 gangliosidosis?

GM1 gangliosidosis is a progressive and fatal pediatric lysosomal storage disorder caused by mutations in the GLB1 gene that cause impaired production of the β-galactosidase enzyme. Currently, there are no FDA-approved treatment options for GM1 gangliosidosis.

What is the Vickers top buyer and seller report?

Daily – Vickers Top Buyers & Sellers for 03/25/2021 The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

What is fair value in accounting?

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

How much has Arvelle Therapeutics raised?

Since December 31, 2020, the Company has raised $49.1 million, of which $37.1 million was received in gross proceeds from public sales of its common stock (including the Suvretta Capital investment) and $11.6 million was received from a non-dilutive transaction (the sale of the Company’s shares in Arvelle Therapeutics).

When will Gavin Corcoran leave Siox?

(NASDAQ: SIOX), a clinical-stage company focused on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases, announced today that Gavin Corcoran, M.D., Chief Research and Development Officer, will be leaving the company effective November 12, 2021, to pursue an opportunity with a private hea

Is Sio's management reasonable?

All forward-looking statements are based on estimates and assumptions by Sio’s management that, although Sio believes to be reasonable, are inherently uncertain. All forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those that Sio expected.